These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 32367746)

  • 41. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection.
    Verdecchia P; Cavallini C; Spanevello A; Angeli F
    Eur J Intern Med; 2020 Jun; 76():14-20. PubMed ID: 32336612
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The interaction of RAAS inhibitors with COVID-19: Current progress, perspective and future.
    Zhang J; Wang M; Ding W; Wan J
    Life Sci; 2020 Sep; 257():118142. PubMed ID: 32712300
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors.
    Sama IE; Ravera A; Santema BT; van Goor H; Ter Maaten JM; Cleland JGF; Rienstra M; Friedrich AW; Samani NJ; Ng LL; Dickstein K; Lang CC; Filippatos G; Anker SD; Ponikowski P; Metra M; van Veldhuisen DJ; Voors AA
    Eur Heart J; 2020 May; 41(19):1810-1817. PubMed ID: 32388565
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients With Coronavirus Disease 2019: Friend or Foe?
    Shyh GI; Nawarskas JJ; Cheng-Lai A
    Cardiol Rev; 2020; 28(4):213-216. PubMed ID: 32496364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists.
    Steckelings UM; Sumners C
    Clin Sci (Lond); 2020 Nov; 134(22):2987-3006. PubMed ID: 33210709
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of Renin-Angiotensin Inhibition on ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Protease Serine 2) Expression: Insights Into COVID-19.
    Wu C; Ye D; Mullick AE; Li Z; Danser AHJ; Daugherty A; Lu HS
    Hypertension; 2020 Oct; 76(4):e29-e30. PubMed ID: 32673509
    [No Abstract]   [Full Text] [Related]  

  • 47. Delineating clinical characteristics and comorbidities among 206 COVID-19 deceased patients in India: Emerging significance of renin angiotensin system derangement.
    Majeed J; Ajmera P; Goyal RK
    Diabetes Res Clin Pract; 2020 Sep; 167():108349. PubMed ID: 32712124
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Age and Multimorbidity Predict Death Among COVID-19 Patients: Results of the SARS-RAS Study of the Italian Society of Hypertension.
    Iaccarino G; Grassi G; Borghi C; Ferri C; Salvetti M; Volpe M;
    Hypertension; 2020 Aug; 76(2):366-372. PubMed ID: 32564693
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies.
    Albini A; Di Guardo G; Noonan DM; Lombardo M
    Intern Emerg Med; 2020 Aug; 15(5):759-766. PubMed ID: 32430651
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacotherapy in COVID-19 patients: a review of ACE2-raising drugs and their clinical safety.
    Akhtar S; Benter IF; Danjuma MI; Doi SAR; Hasan SS; Habib AM
    J Drug Target; 2020; 28(7-8):683-699. PubMed ID: 32700580
    [TBL] [Abstract][Full Text] [Related]  

  • 51. COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure.
    Siniorakis E; Arvanitakis S; Nikolopoulos I; Elkouris M
    mBio; 2020 May; 11(3):. PubMed ID: 32444383
    [No Abstract]   [Full Text] [Related]  

  • 52. Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System: Pressing Needs and Best Research Practices.
    Sparks MA; South AM; Badley AD; Baker-Smith CM; Batlle D; Bozkurt B; Cattaneo R; Crowley SD; Dell'Italia LJ; Ford AL; Griendling K; Gurley SB; Kasner SE; Murray JA; Nath KA; Pfeffer MA; Rangaswami J; Taylor WR; Garovic VD
    Hypertension; 2020 Nov; 76(5):1350-1367. PubMed ID: 32981369
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship Between ACE2 and Other Components of the Renin-Angiotensin System.
    Cohen JB; Hanff TC; Bress AP; South AM
    Curr Hypertens Rep; 2020 Jun; 22(7):44. PubMed ID: 32591908
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SARS-CoV-2 downregulation of ACE2 and pleiotropic effects of ACEIs/ARBs.
    Ciulla MM
    Hypertens Res; 2020 Sep; 43(9):985-986. PubMed ID: 32523133
    [No Abstract]   [Full Text] [Related]  

  • 55. COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease.
    Tomasoni D; Italia L; Adamo M; Inciardi RM; Lombardi CM; Solomon SD; Metra M
    Eur J Heart Fail; 2020 Jun; 22(6):957-966. PubMed ID: 32412156
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of renin-angiotensin-aldosterone system inhibitors on COVID-19.
    Matsuzawa Y; Kimura K; Ogawa H; Tamura K
    Hypertens Res; 2022 Jul; 45(7):1147-1153. PubMed ID: 35581498
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Yin and Yang of ACE/ACE2 Pathways: The Rationale for the Use of Renin-Angiotensin System Inhibitors in COVID-19 Patients.
    Zamai L
    Cells; 2020 Jul; 9(7):. PubMed ID: 32708755
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Angiotensin II receptors: Impact for COVID-19 severity.
    Aksoy H; Karadag AS; Wollina U
    Dermatol Ther; 2020 Nov; 33(6):e13989. PubMed ID: 32645228
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Understanding the renin-angiotensin-aldosterone-SARS-CoV axis: a comprehensive review.
    Ingraham NE; Barakat AG; Reilkoff R; Bezdicek T; Schacker T; Chipman JG; Tignanelli CJ; Puskarich MA
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32341103
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system.
    Offringa A; Montijn R; Singh S; Paul M; Pinto YM; Pinto-Sietsma SJ
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):317-325. PubMed ID: 32464637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.